CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 318 enrolled
Drug / intervention
Laceration Repair with Polyglactin 910 +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03184077
NCT03184077N/ACompleted
CompareCT.gov

Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair: A Randomized Controlled Trial

Virginia Commonwealth University·interventional·Posted Jun 12, 2017·Updated Aug 28, 2019

In Brief

A clinical study evaluating Laceration Repair with Polyglactin 910 and Laceration Repair with poliglecaprone 25 for Dyspareunia and 2 related conditions. Completed, enrolled 318 participants across 1 site.

Detailed Summary

To evaluate the rates of dyspareunia with rapidly absorbing polyglactin 910 compared to poliglecaprone 25 using a validated sexual function questionnaire. To assess maternal satisfaction with the laceration repair and suture material. To assess overall perineal pain using a visual analog scale. To assess the rate of wound breakdown and the need for suture removal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspareunia, Perineal Tear, Sutured Laceration
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 12, 2017
Enrollment StartSep 2, 2014
Primary CompletionAug 27, 2017
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 9.1 years ago

Interventions

Laceration Repair with Polyglactin 910procedure

Polyglactin 910 suture for laceration repair

Laceration Repair with poliglecaprone 25procedure

poliglecaprone 25 suture for laceration repair